Related Experiment Video

Updated: Nov 1, 2025

Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
05:07

Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice

Published on: August 25, 2023

1.6K

Factors associated with microvascular occlusion in patients with ST elevation myocardial infarction after primary

Yinhao Huang1, Dazhou Lei1, Ziwei Chen1

  • 1Department of Cardiology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, China.

The Journal of International Medical Research
|June 22, 2021
PubMed

Insights

Predictors of microvascular occlusion (MVO) after ST-elevation myocardial infarction (STEMI) primary percutaneous coronary intervention (pPCI) were identified. C-reactive protein, troponin T, and syndecan-1 levels predict MVO, aiding patient risk stratification.

Area of Science:

  • Cardiology
  • Biomarker Research

Background:

  • Microvascular occlusion (MVO) is a complication following ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (pPCI).
  • Predicting MVO is crucial for patient outcomes and therapeutic strategies.

Purpose of the Study:

  • To identify serum biomarkers that predict the occurrence of MVO in STEMI patients post-pPCI.
  • To evaluate the independent association of specific biomarkers with MVO development.

Main Methods:

  • Retrospective observational study of 113 STEMI patients undergoing pPCI.
  • Cardiac magnetic resonance imaging (CMR) to assess MVO.
  • Multivariable logistic regression analysis of serum biomarkers measured 1 day post-pPCI.

Main Results:

  • C-reactive protein (CRP), troponin T (TnT), and syndecan-1 were significantly higher in patients with MVO.
  • CRP (HR=1.036), TnT (HR=1.316), and syndecan-1 (HR=1.986) were independently associated with MVO.
  • These biomarkers can help identify patients at higher risk for MVO.

Conclusions:

  • Serum levels of CRP, TnT, and syndecan-1 are significant predictors of MVO in STEMI patients after pPCI.
  • These biomarkers offer potential for early risk assessment and targeted interventions.
Abstract

Keywords:
C-reactive proteinMicrovascular occlusionST elevation myocardial infarctionprimary percutaneous coronary interventionsyndecan-1troponin T

More Related Videos

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.6K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.9K

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
201
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
86
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
102
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
58
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
125
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
69